BR9815219A - Use of thiazolidinediones for the treatment of hyperglycemia - Google Patents
Use of thiazolidinediones for the treatment of hyperglycemiaInfo
- Publication number
- BR9815219A BR9815219A BR9815219-0A BR9815219A BR9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- hyperglycemia
- thiazolidinediones
- thiazolidinedions
- mammal
- Prior art date
Links
- 201000001421 hyperglycemia Diseases 0.000 title abstract 3
- 229940123464 Thiazolidinedione Drugs 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"USO DE TIAZOLIDINEDIONAS PARA O TRATAMENTO DA HIPERGLICEMIA" A presente invenção refere-se a um método para o tratamento da hiperglicemia onde os níveis plasmáticos de glicose na faixa de normal a elevada para <243>126 mg/dl, cujo método compreende a administração de uma quantidade eficaz, não-tóxica e farmaceuticamente aceitável de um sensibilizador da insulina, para um mamífero que necessite do tratamento."USE OF THIAZOLIDINEDIONS FOR THE TREATMENT OF HYPERGLYCEMIA" The present invention relates to a method for the treatment of hyperglycemia where plasma glucose levels in the range from normal to elevated to <243> 126 mg / dl, the method of which comprises administration of an effective, non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, for a mammal in need of treatment.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721693.1A GB9721693D0 (en) | 1997-10-13 | 1997-10-13 | Novel treatment |
| PCT/GB1998/003064 WO1999018943A1 (en) | 1997-10-13 | 1998-10-12 | Use of thiazolidinediones for the treatment of hyperglycaemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815219A true BR9815219A (en) | 2001-01-02 |
Family
ID=10820482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815219-0A BR9815219A (en) | 1997-10-13 | 1998-10-12 | Use of thiazolidinediones for the treatment of hyperglycemia |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1023056A1 (en) |
| JP (1) | JP2001519382A (en) |
| KR (1) | KR20010024481A (en) |
| CN (1) | CN1281359A (en) |
| AP (1) | AP2000001787A0 (en) |
| AU (1) | AU9547098A (en) |
| BG (1) | BG104404A (en) |
| BR (1) | BR9815219A (en) |
| CA (1) | CA2306086A1 (en) |
| CZ (1) | CZ20001297A3 (en) |
| EA (1) | EA002659B1 (en) |
| GB (1) | GB9721693D0 (en) |
| HR (1) | HRP20000255A2 (en) |
| HU (1) | HUP0003922A3 (en) |
| ID (1) | ID24521A (en) |
| IL (1) | IL135513A0 (en) |
| NO (1) | NO20001898L (en) |
| NZ (1) | NZ503862A (en) |
| OA (1) | OA11683A (en) |
| PL (1) | PL339813A1 (en) |
| SK (1) | SK5312000A3 (en) |
| TR (1) | TR200000958T2 (en) |
| WO (1) | WO1999018943A1 (en) |
| YU (1) | YU28800A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856378T2 (en) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
-
1997
- 1997-10-13 GB GBGB9721693.1A patent/GB9721693D0/en not_active Ceased
-
1998
- 1998-10-12 AU AU95470/98A patent/AU9547098A/en not_active Abandoned
- 1998-10-12 HU HU0003922A patent/HUP0003922A3/en unknown
- 1998-10-12 PL PL98339813A patent/PL339813A1/en unknown
- 1998-10-12 EA EA200000419A patent/EA002659B1/en not_active IP Right Cessation
- 1998-10-12 EP EP98949086A patent/EP1023056A1/en not_active Withdrawn
- 1998-10-12 AP APAP/P/2000/001787A patent/AP2000001787A0/en unknown
- 1998-10-12 WO PCT/GB1998/003064 patent/WO1999018943A1/en not_active Ceased
- 1998-10-12 CZ CZ20001297A patent/CZ20001297A3/en unknown
- 1998-10-12 KR KR1020007003934A patent/KR20010024481A/en not_active Ceased
- 1998-10-12 CN CN98812083A patent/CN1281359A/en active Pending
- 1998-10-12 JP JP2000515578A patent/JP2001519382A/en active Pending
- 1998-10-12 BR BR9815219-0A patent/BR9815219A/en not_active Application Discontinuation
- 1998-10-12 NZ NZ503862A patent/NZ503862A/en unknown
- 1998-10-12 TR TR2000/00958T patent/TR200000958T2/en unknown
- 1998-10-12 IL IL13551398A patent/IL135513A0/en unknown
- 1998-10-12 ID IDW20000669A patent/ID24521A/en unknown
- 1998-10-12 HR HR20000255A patent/HRP20000255A2/en not_active Application Discontinuation
- 1998-10-12 SK SK531-2000A patent/SK5312000A3/en unknown
- 1998-10-12 OA OA1200000108A patent/OA11683A/en unknown
- 1998-10-12 YU YU28800A patent/YU28800A/en unknown
- 1998-10-12 CA CA002306086A patent/CA2306086A1/en not_active Abandoned
-
2000
- 2000-04-12 NO NO20001898A patent/NO20001898L/en not_active Application Discontinuation
- 2000-05-05 BG BG104404A patent/BG104404A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010024481A (en) | 2001-03-26 |
| IL135513A0 (en) | 2001-05-20 |
| AU9547098A (en) | 1999-05-03 |
| EA002659B1 (en) | 2002-08-29 |
| CN1281359A (en) | 2001-01-24 |
| HRP20000255A2 (en) | 2001-02-28 |
| EP1023056A1 (en) | 2000-08-02 |
| NO20001898L (en) | 2000-06-09 |
| CZ20001297A3 (en) | 2001-08-15 |
| PL339813A1 (en) | 2001-01-02 |
| HUP0003922A3 (en) | 2001-12-28 |
| HUP0003922A2 (en) | 2001-10-28 |
| NZ503862A (en) | 2003-01-31 |
| NO20001898D0 (en) | 2000-04-12 |
| BG104404A (en) | 2000-12-29 |
| EA200000419A1 (en) | 2000-10-30 |
| ID24521A (en) | 2000-07-20 |
| TR200000958T2 (en) | 2000-08-21 |
| OA11683A (en) | 2005-01-12 |
| CA2306086A1 (en) | 1999-04-22 |
| YU28800A (en) | 2003-02-28 |
| JP2001519382A (en) | 2001-10-23 |
| WO1999018943A1 (en) | 1999-04-22 |
| SK5312000A3 (en) | 2000-09-12 |
| AP2000001787A0 (en) | 2000-06-30 |
| GB9721693D0 (en) | 1997-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911656A (en) | Pharmaceutical composition, processes for the prevention or treatment of diabetes in a mammal, for the prevention or treatment of diabetic complications in a mammal and for the prevention or treatment of impaired glucose tolerance in a mammal, use of an insulin sensitizer, and, process to reduce the side effects of an insulin sensitizer or / and an anoretic administered to a diabetic mammal | |
| BR9811793A (en) | Biodegradable macromers for the controlled release of biologically active substances. | |
| NO20090846L (en) | Combination and pharmaceutical composition for the treatment of diabetes and its use | |
| BR0016012A (en) | Pharmaceutical implant containing immediate and prolonged release components, as well as administration process | |
| BR9807974A (en) | Pharmaceutical composition for prolonged release of an erythromycin derivative in the gastrointestinal environment, and process for using the same | |
| KR960000924A (en) | Insulin analogue combination | |
| PT1137416E (en) | USE OF DERIVATIVES OF LONG-STRANDED NON-CURRENT ALKYL OF DEOXINOJYRIMICIN FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF DISEASES CONNECTED TO THE STORAGE OF GLYCOLIPIDOS | |
| BR9911112A (en) | Glucagon-like petpìdeo-1 improves ß-cell response to glucose in patients with impaired glucose tolerance | |
| NO944803L (en) | Controlled release pharmaceutical preparation | |
| AR024228A1 (en) | A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN SENSITIZER AND ANOTHER ANTI-DIABETIC AGENT | |
| BR9808888A (en) | Dosage forms and method of improving male erectile dysfunction | |
| AR013742A1 (en) | METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE | |
| NO970317L (en) | Use of DHA in a pharmaceutical composition | |
| BR9908510A (en) | Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease | |
| BR9809492A (en) | Injectable aqueous pharmaceutical composition, and process for preparing it | |
| BR9810445A (en) | Diabetes treatment with thiazolidinedione, insulin secretagogue and diguanide | |
| CY1107745T1 (en) | TREATMENT OF DIABETES WITH THIAZOLIDINODION AND SULFONYLURIA | |
| BR9810444A (en) | Treatment of diabetes with rosiglitazone and insulin | |
| ES2196167T3 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PROPIONATE 3- (2,2,2-TRIMETHYL HYDRAZINY) AND GAMMA-BUTIROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. | |
| BR9809673A (en) | Triptolide derivatives useful in the treatment of autoimmune diseases | |
| BR9810292A (en) | Diabetes treatment with thiazolidinedione, insulin secretagogue and alpha-glucosidase inhibitor | |
| BR9810186A (en) | Diabetes treatment with thiazolidinedione and alpha-glycosity inhibitor | |
| US6589995B2 (en) | Method of inhibiting pancreatic β-cell p135 O-glycosylation | |
| BR0307218A (en) | Extended Release Pharmaceutical Composition | |
| BR9815220A (en) | Use of thiazolidinediones for the treatment of hyperglycemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |